Home / News / Breast Biopsy Devices Market Expected To Reach USD 1,250.71 Mn By 2022 – Credence Research

Breast Biopsy Devices Market Expected To Reach USD 1,250.71 Mn By 2022 – Credence Research

The latest market report published by Credence Research “Global Breast Biopsy Devices Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the breast biopsy devices market was valued at USD 617.62 Mn in 2015, and is expected to reach USD 1,250.71 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.

Browse the full report Breast Biopsy Devices Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/breast-biopsy-devices-market

Market Insights

Breast cancer is among the most commonly diagnosed non-skin cancer across the world, with among the highest annual mortality. While the incidence of the disease is increasing at alarming rates in the developing markets, the breast cancer survival prognosis is reported to be con tenuously improving this proving development in the trends of early disease diagnosis and treatment outcomes. Pathological detection of breast cancer has evolved a long way until present with biopsy becoming the standard route of disease detection. With the introduction of minimally invasive biopsy procedures, intimating with fine needle aspiration, the global breast biopsy devices market has witnessed phenomenal growth over the period.

Browse the full report Breast Biopsy Devices Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/breast-biopsy-devices-market

Rapidly aging population and the proven correlation of age with the incidence of breast cancer is among the biggest contributors to the breast biopsy devices market. Alarming disease incidence and technological development resulting in rapid adoption of breast biopsy devices and related solutions are observed to be the major market drivers in the developing regions of the world. Introduction of guidance enabled biopsy systems has further facilitated the market development and assisted in containment of breast cancer incidence.

Market Competition Assessment

The global breast biopsy devices market is consolidated with a few players dominating the major chunk of the market revenue. Players such as Hologic, Mammotome, C.R. Bar, Inc. are identified and recognized as the global market leaders. Other players such as Argon Medical Devices, Becton Dickinson and Company, Sterylab are the promising market players with their established positions in prime market segments.

Key Market Movements

Increased preference for minimally invasive biopsies
Rapid shift towards guided biopsies
Growth in adoption of disposable consumables

Latest Reports:

Medical Imaging Equipment Market By Product Type (X-Ray Devices, Ultrasound Systems, Computer Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Equipment, Nuclear Imaging Equipment), By Technology (X-Ray Devices, Ultrasound Systems, Computer Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Equipment, Nuclear Imaging Equipment) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022

Nurse Call System Market By Product (Buttons, Intercom Systems, Mobile Nurse Call Systems, Integrated Nurse Call Systems), By Application (Hospitals, OPD Clinics, Assisted Living Centers, Ambulatory Services), By Technology (Wired Nurse Call Systems, Wireless Nurse Call Systems) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

Biopsy Devices Market By Product (Biopsy Guidance Systems, Biopsy Needles, Needle-based Biopsy Guns, Biopsy Forceps) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

Contact:

Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research

 

Release ID: 2896

About Chris Smith

Check Also

400-400

Worldwide Survey: Contraceptives Sales Market 2016 to 2022 Size, Share, analysis,Trends and Forecast By Acute Market Reports

Report Description: Notes: Sales, means the sales volume of Contraceptives Revenue, means the sales value ...